Effects of cross-sex hormone treatment on transgender women and men

Obstetrics and Gynecology
Madeline B DeutschKatrina Kubicek

Abstract

To describe weight, body mass index (BMI), blood pressure (BP), lipids, and hormone levels in transgender women and men presenting for initiation of cross-sex hormone therapy at a community clinic in the United States. Twenty-three transgender women (persons assigned male at birth who identify as female and want to use estrogen to develop female secondary sex characteristics) and 34 transgender men (persons assigned female at birth who identify as male and want to use testosterone to develop male secondary sex characteristics) presenting for initiation of hormone therapy at a community health center were enrolled. Body mass index, BP, lipids, and sex hormone levels were measured at baseline and 6 months. Persistence of menses at 6 months in transgender men was recorded. Sixteen transgender women and 31 transgender men completed the study. Baseline and 6-month median BPs and lipid values were within a normal clinical range. Median systolic BP in transgender women dropped from baseline 130.5 mmHg (interquartile range 11.5) to 120.5 mmHg (interquartile range 15.5) at 6 months (P=.006). Testosterone levels remained elevated in 33% and estradiol (E2) levels were supratherapeutic in 19% of transgender women at 6 months. Median BMI fo...Continue Reading

References

Nov 18, 2006·American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics·Vance J DykhouseS Ed Owens
Dec 15, 2006·Human Reproduction·Tsuyoshi BabaTsuyoshi Saito
Dec 26, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·G De CuypereS Monstrey
Nov 8, 2007·The Journal of Clinical Endocrinology and Metabolism·Louis J GoorenMathijs C Bunck
Jun 11, 2009·The Journal of Clinical Endocrinology and Metabolism·Wylie C HembreeUNKNOWN Endocrine Society
Jul 3, 2009·The Journal of Sexual Medicine·Anna Myriam PerroneMaria Cristina Meriggiola
Apr 1, 2011·The New England Journal of Medicine·Louis J Gooren
May 21, 2011·The Journal of Sexual Medicine·Johannes OttUlrike Kaufmann
Jul 17, 2013·Archives of Sexual Behavior·Lisette Kuyper, Ciel Wijsen

❮ Previous
Next ❯

Citations

May 27, 2016·LGBT Health·Jacob C WarrenK Nikki Barefoot
Nov 1, 2016·Balsaeng'gwa saengsig·Hye Rim Byeon, Sung-Ho Lee
Jun 2, 2017·European Journal of Endocrinology·Lina SchifferMichael W O'Reilly
Feb 27, 2018·Plastic and Reconstructive Surgery·Jason M WeisslerIvona Percec
Feb 7, 2018·Journal of American College Health : J of ACH·Whitney R Linsenmeyer, Rabia Rahman
Mar 22, 2018·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Kelly J ChanJoshua D Safer
Nov 22, 2017·Transgender Health·Shazia Ahmad, Matthew Leinung
Jun 15, 2018·Journal of Clinical Pharmacology·Melanie R NicolMackenzie L Cottrell
Apr 7, 2018·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Kelly J ChanJoshua D Safer
Oct 12, 2018·Endocrine Reviews·Guy T'SjoenVin Tangpricha
Feb 28, 2019·LGBT Health·John David FernandezLisa R Tannock
May 18, 2016·Journal of the American Society of Nephrology : JASN·Vesna D Garovic, Phyllis August
Feb 11, 2019·Clinical Pharmacology and Therapeutics·Aaron S DevanathanAngela D M Kashuba
Oct 3, 2019·Revista brasileira de epidemiologia = Brazilian journal of epidemiology·Alícia KrügerEdgar Merchán-Hamann
Dec 7, 2018·Clinical Chemistry·Jeffrey A SoRelleKhushbu Patel
Jun 13, 2019·Obstetrics and Gynecology·Amanda R SchwartzBeverly A Gray
Oct 23, 2019·The Journal of Applied Laboratory Medicine·Robert M HumbleMatthew D Krasowski
Apr 7, 2020·Expert Opinion on Drug Metabolism & Toxicology·Jenna L Yager, Peter L Anderson
Jan 31, 2016·Current Opinion in Endocrinology, Diabetes, and Obesity·Jamie FeldmanJoshua D Safer
Jun 23, 2020·Clinical Obstetrics and Gynecology·Allison C MayhewVeronica Gomez-Lobo
Feb 3, 2018·Current Radiology Reports·Emily B SonnenblickTamar Reisman
May 15, 2018·Transgender Health·Matthew C LeinungJalaja Joseph
Sep 5, 2018·JAMA Internal Medicine·Nicole RosendaleLawrence A Haber
May 21, 2020·Journal of Assisted Reproduction and Genetics·Hadar AmirAvi Ben-Haroush
Sep 26, 2017·The Journal of Clinical Endocrinology and Metabolism·Spyridoula MarakaM Hassan Murad
Sep 14, 2019·Therapeutic Advances in Endocrinology and Metabolism·Sean J IwamotoGuy T'Sjoen
Apr 10, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mackenzie L CottrellAngela D M Kashuba
Jul 31, 2018·Journal of the Endocrine Society·Ferdinand RoelfsemaJohannes D Veldhuis
Dec 25, 2019·Transgender Health·Heather E Schier, Whitney R Linsenmeyer
Aug 19, 2020·Journal of Hypertension·Paul J ConnellyChristian Delles
Aug 19, 2020·The Journal of Clinical Endocrinology and Metabolism·Ada S CheungJeffrey D Zajac

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.